Cleared Special

K020127 - SMARTFLOW PULSE TRANSMISSION COEFFICIENT

K020127 is an FDA 510(k) clearance for SMARTFLOW PULSE TRANSMISSION COEFFICIENT, manufactured by Florence Medical , Ltd.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2002
Decision
30d
Days
Class 2
Risk

K020127 is an FDA 510(k) clearance for the SMARTFLOW PULSE TRANSMISSION COEFFICIENT. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Florence Medical , Ltd. (Ra'Ananna 43373, IL). The FDA issued a Cleared decision on February 14, 2002 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Florence Medical , Ltd. devices

FDA 510(k) Submission Details - K020127

510(k) Number K020127 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 15, 2002
Decision Date February 14, 2002
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 375
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K020127.
QUINTON Q-CATH, MODEL 000460
K021906 · Quinton, Inc. · Sep 2002
MAC-LAB/CARDIOLAB EP/COMBOLAB
K021366 · General Electric Medical Systems Information Techn · Jul 2002
PHYSIOLOG, SERIES 95000
K013032 · Camtronics, Ltd. · Jun 2002
MAC 5000 ECG ANALYSIS SYSTEM
K014108 · General Electric Medical Systems Information Techn · Jan 2002
CARTO XP EP NAVIGATION SYSTEM
K013083 · Biosense Webster, Inc. · Nov 2001
ALTERNANAS PROCESSING SYSTEM, CH 2000 CARDIAC DIAGNOSTIC SYSTEM, HEARTWAVE ALTERNANS PROCESSING SYSTEM
K012206 · Cambridge Heart, Inc. · Oct 2001